We are live on ! Find out more
TRIM

Thompson Rubinstein Investment Management Portfolio holdings

AUM $311M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.81%
5 Year Est. Return
+48.65%
10 Year Est. Return
–
AUM
$275M
AUM Growth
+$5.69M
Cap. Flow
-$2.84M
Cap. Flow %
-1.03%
Top 10 Hldgs %
39.92%
Holding
79
New
2
Increased
5
Reduced
50
Closed
–

Top Buys

Rank Stock Value
1
BIVV
Bioverativ Inc. Common Stock
BIVV
+$831K
2
QEP
QEP RESOURCES, INC.
QEP
+$600K
3
VREX icon
Varex Imaging
VREX
+$461K
4
CVS icon
CVS Health
CVS
+$252K
5
ABBV icon
AbbVie
ABBV
+$61.1K

Top Sells

Rank Stock Value
1
VAR
Varian Medical Systems, Inc.
VAR
+$517K
2
BIIB icon
Biogen
BIIB
+$297K
3
WBA
Walgreens Boots Alliance
WBA
+$281K
4
HUBB icon
Hubbell
HUBB
+$272K
5
JNJ icon
Johnson & Johnson
JNJ
+$219K

Sector Composition

Rank Sector Weight
1 Healthcare 27.31%
2 Industrials 23.16%
3 Technology 16.41%
4 Energy 10.11%
5 Consumer Staples 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WST icon
76
West Pharmaceutical
WST
$25B
$326K 0.12%
4,000
– –
ING icon
77
ING
ING
$102B
$308K 0.11%
20,388
– –
CBT icon
78
Cabot Corp
CBT
$4.52B
$288K 0.1%
4,800
– –
LEG icon
79
Leggett & Platt
LEG
$1.31B
$277K 0.1%
5,500
– –
1 2 3
4

Similar funds

CFS
Ceros Financial Services Rockville, Maryland $316M AUM
SVWA
Sound View Wealth Advisors Savannah, Georgia $319M AUM
SAS
Sarbit Advisory Services Winnipeg, Manitoba, Canada $294M AUM 0.68% 1-Year Est. Return
LYV
Live Your Vision West Conshohocken, Pennsylvania $330M AUM 2.28% 1-Year Est. Return
TAT
TD Ameritrade Trust Denver, Colorado $285M AUM 0.17% 1-Year Est. Return
NAP
New Amsterdam Partners New York $272M AUM 12.21% 1-Year Est. Return
OAMU
Ostrum Asset Management US New York $359M AUM
TCM
Tradition Capital Management Summit, New Jersey $369M AUM 6.72% 1-Year Est. Return

Thompson Rubinstein Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Thompson Rubinstein Investment Management held 79 positions worth $275M, up 2.1% from $270M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trading was light in Q1 2017: portfolio turnover was 2.5%. Thompson Rubinstein Investment Management opened 2 new positions and made no exits, leaving the 79-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Technology.

  • Thompson Rubinstein Investment Management's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 16,864 shares worth $918K.
  • Thompson Rubinstein Investment Management added most to QEP RESOURCES, INC. in Q1 2017, an estimated $600K increase.
  • Thompson Rubinstein Investment Management's biggest Q1 2017 reduction was Varian Medical Systems, Inc., cutting an estimated $517K.
  • Thompson Rubinstein Investment Management's ten largest holdings make up 40% of its $275M portfolio in Q1 2017.
  • Thompson Rubinstein Investment Management opened 2 new positions and closed 0 in Q1 2017.
  • Thompson Rubinstein Investment Management's portfolio value rose 2.1% quarter-over-quarter to $275M.

Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2017, filed 6 Apr 2017.